Is it safe for a pregnant patient to use bupropion (Wellbutrin) XL 150 mg and fluoxetine (Prozac) 20 mg to treat anxiety and mild depression with loss of motivation and energy?

Wellbutrin 150 XL and Prozac 20 During Pregnancy for Anxiety and Mild Depression

For a pregnant patient with anxiety and mild depression with loss of motivation and energy, fluoxetine (Prozac) 20 mg can be continued with reasonable safety, while bupropion (Wellbutrin) XL 150 mg should be used with caution due to possible small increases in specific cardiovascular malformations, though the absolute risk remains low.

Evidence-Based Approach to This Combination

Bupropion (Wellbutrin XL 150 mg)

According to the most recent 2024 guideline from the American Journal of Obstetrics and Gynecology, bupropion does not appear to be associated with major congenital malformations or significant adverse obstetrical outcomes overall, though data are limited 1. However, there are important nuances:

Specific cardiovascular concerns:

• Small absolute increase in risk of left ventricular outflow tract obstruction (incidence 0.279% vs 0.07% with other antidepressants) 1
• Ventricular septal defects (adjusted OR 2.9; 95% CI 1.5-5.5) 1
• Possible increased risk for diaphragmatic hernia (adjusted OR 2.77; 95% CI 1.34-5.71), though absolute risk is extremely low given population prevalence of only 0.012%-0.031% 1

Critical caveat: Confounding by indication cannot be ruled out in these studies, and other studies have not consistently found these associations 1. The FDA label confirms bupropion can be used during pregnancy but advises discussing risks with patients 2.

Obstetrical outcomes:

• Possible increased risk for spontaneous abortion 1, which was confirmed in a 2005 prospective study (P = 0.009) 3, though rates remained within general population ranges
• One case report of poor neonatal adaptation with seizures due to hypoglycemia 1

Fluoxetine (Prozac 20 mg)

While the provided evidence focuses heavily on bupropion, fluoxetine is generally considered one of the better-studied SSRIs in pregnancy. A 2011 review noted that SSRIs like fluoxetine are "generally considered to be relatively safe when used during pregnancy" 4.

Key considerations for fluoxetine:

• More established safety profile compared to bupropion
• Better studied for anxiety symptoms in pregnancy
• Lower risk of cardiovascular malformations compared to paroxetine

For This Specific Clinical Scenario

Given the presentation of anxiety AND mild depression with loss of motivation/energy:

1. Fluoxetine (Prozac) 20 mg should be continued - SSRIs have stronger evidence for treating anxiety symptoms in pregnancy, and fluoxetine has a well-established safety profile

2. Bupropion (Wellbutrin) XL 150 mg requires careful risk-benefit discussion:

   • The dose of 150 mg daily is within the recommended starting range 1
   • If the patient has been stable on this combination pre-pregnancy, continuing may be reasonable given that untreated depression carries its own risks
   • If this is a new prescription during pregnancy, consider whether fluoxetine alone at a potentially higher dose might suffice, given bupropion's less robust evidence for anxiety

Clinical Decision Algorithm

Step 1: Assess severity and treatment history

• If patient was stable on this combination pre-pregnancy → Continue both with informed consent about small cardiovascular risks
• If newly pregnant and considering starting treatment → Fluoxetine monotherapy may be preferable

Step 2: Counsel on specific risks

• Discuss the small absolute increase in cardiovascular malformations with bupropion (particularly left ventricular outflow tract obstruction and ventricular septal defects)
• Emphasize that absolute risks remain low and confounding factors may explain associations
• Discuss risks of untreated depression and anxiety on pregnancy outcomes

Step 3: Monitoring plan

• Fetal echocardiography at 18-22 weeks if continuing bupropion to screen for cardiac malformations
• Monitor blood pressure regularly (bupropion can cause hypertension) 2
• Monitor for signs of poor neonatal adaptation at delivery
• Ensure appropriate weight gain throughout pregnancy 1

Step 4: Consider alternatives if patient declines bupropion

• Increase fluoxetine dose if needed for depressive symptoms
• Add cognitive behavioral therapy for anxiety and depression
• Consider sertraline as alternative SSRI with good pregnancy data

Important Pitfalls to Avoid

1. Do not abruptly discontinue either medication - Risk of relapse may outweigh theoretical medication risks, and untreated maternal depression has well-documented adverse effects on pregnancy outcomes 5

2. Do not assume bupropion is contraindicated - While caution is advised, the 2024 guideline states it "does not seem to be associated with major congenital malformations" overall 1

3. Do not overlook the anxiety component - Bupropion has mixed effects on anxiety (can be anxiolytic or anxiogenic) 6, while SSRIs like fluoxetine have more consistent anxiolytic effects

4. Do not forget to document informed consent - Given the nuanced risk profile, thorough documentation of the risk-benefit discussion is essential

Strength of Evidence Assessment

The 2024 AJOG guideline [1-1 represents the most recent and authoritative source, though it acknowledges data limitations. The evidence for bupropion safety is weaker than for SSRIs, with most associations showing possible confounding by indication. The recommendation to use "caution" rather than "contraindication" reflects this uncertainty while acknowledging real-world clinical need for effective treatment.